Both Novo Nordisk and the Food and Drug Administration are trying to severely squash this market, however, meaning peoples easy access to these riskier products may dry up sooner rather than later
The safety and efficacy of liraglutide injection was evaluated in a 26-week clinical study that included patients with moderate renal impairment (eGFR 30 to 60 mL/min/1.73m 2) [see Clinical Studies (14.1)]
The 0.3 ml syringe (30 units total) is the smallest option
The overall experience with each is relatively similar, but Transparent Labs has usually caused us the fewest headaches
Stick to approved areas only : abdomen, thigh, or upper arm
By staying hydrated, rotating your injection sites, and maintaining open communication with your healthcare team, you can move past these hurdles